_id
6919eddc3c536f8df2318493
Ticker
SCLP.LSE
Name
Scancell Hldgs Plc
Exchange
LSE
Address
Bellhouse Building, Oxford, United Kingdom, OX4 4GD
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://www.scancell.co.uk
Description
Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer. It also develops Modi-1, an active peptide immunotherapy that is in phase II clinical trials for the treatment of solid tumors, including renal, head and neck, ovarian and triple negative breast cancers; and Modi-2, which targets stress-induced post translational modifications, such as homocittrullination. In addition, the company provides GlyMab platform that generates various affinity tumour specific monoclonal antibodies (mAb) targeting glycans that are over-expressed on cancer cells; and AvidiMab, which romotes receptor clustering thereby improving immune signalling. Scancell Holdings plc was founded in 1996 and is based in Oxford, the United Kingdom.
Last Close
97500
Volume
286854
Current Price
11.83
Change
1.538461538461542
Last Updated
2025-12-30T11:30:08.902Z
Image
https://logo.clearbit.com/www.scancell.co.uk
Ipo Date
-
Market Cap
101183680
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-04-30
Revenue
4711000
Cost Of Revenue
638000
Gross Profit
4073000
Operating Expenses
8529000
Operating Income
-4456000
Interest Expense
924000
Pretax Income
-1466000
Net Income
231000
Eps
0.00023806616246774964
Dividends Per Share
-
Shares Outstanding
1037781403
Income Tax Expense
-1697000
EBITDA
-142000
Operating Margin
-94.58713648906813
Total Other Income Expense Net
2990000
Cash
16894000
Short Term Investments
-
Receivables
3730000
Inventories
-
Total Current Assets
20624000
Property Plant Equipment
847000
Total Assets
23090000
Payables
606000
Short Term Debt
16143999
Long Term Debt
0
Total Liabilities
26925000
Equity
-3835000
Bs_currency_symbol
GBP
Depreciation
400000
Change In Working Capital
-948000
Cash From Operations
-1267000
Capital Expenditures
14000
Cash From Investing
-1342000
Cash From Financing
10351000
Net Change In Cash
7791000
Cf_currency_symbol
-
PE
-
PB
-2993.185859762712
ROE
-6.023468057366363
ROA
1.000433087916847
FCF
-1281000
Fcf Percent
-0.27191679049034173
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
0.5
Quality Investing Score
1
Value Investing Score
3.5
Quarters > 0 > quarter
2025-04-30
Quarters > 0 > income Statement > revenue
4711000
Quarters > 0 > income Statement > cost Of Revenue
638000
Quarters > 0 > income Statement > gross Profit
4073000
Quarters > 0 > income Statement > operating Expenses
8529000
Quarters > 0 > income Statement > operating Income
-4456000
Quarters > 0 > income Statement > interest Expense
924000
Quarters > 0 > income Statement > pretax Income
-1466000
Quarters > 0 > income Statement > net Income
231000
Quarters > 0 > income Statement > eps
0.00023806616246774964
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
970318493
Quarters > 0 > income Statement > income Tax Expense
-1697000
Quarters > 0 > income Statement > EBITDA
-142000
Quarters > 0 > income Statement > operating Margin
-94.58713648906813
Quarters > 0 > income Statement > total Other Income Expense Net
2990000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
16894000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
3730000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
20624000
Quarters > 0 > balance Sheet > property Plant Equipment
847000
Quarters > 0 > balance Sheet > total Assets
23090000
Quarters > 0 > balance Sheet > payables
606000
Quarters > 0 > balance Sheet > short Term Debt
16143999
Quarters > 0 > balance Sheet > long Term Debt
0
Quarters > 0 > balance Sheet > total Liabilities
26925000
Quarters > 0 > balance Sheet > equity
-3835000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
231000
Quarters > 0 > cash Flow > depreciation
400000
Quarters > 0 > cash Flow > change In Working Capital
-948000
Quarters > 0 > cash Flow > cash From Operations
-1267000
Quarters > 0 > cash Flow > capital Expenditures
14000
Quarters > 0 > cash Flow > cash From Investing
-1342000
Quarters > 0 > cash Flow > cash From Financing
10351000
Quarters > 0 > cash Flow > net Change In Cash
7791000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.00023806616246774964
Quarters > 0 > ratios > PB
-2993.185859762712
Quarters > 0 > ratios > ROE
-6.023468057366363
Quarters > 0 > ratios > ROA
1.000433087916847
Quarters > 0 > ratios > FCF
-1281000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.27191679049034173
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2024-10-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
479000
Quarters > 1 > income Statement > gross Profit
-479000
Quarters > 1 > income Statement > operating Expenses
10066000
Quarters > 1 > income Statement > operating Income
-10545000
Quarters > 1 > income Statement > interest Expense
793000
Quarters > 1 > income Statement > pretax Income
-13837000
Quarters > 1 > income Statement > net Income
-12503000
Quarters > 1 > income Statement > eps
-0.013452692851878353
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
929405000
Quarters > 1 > income Statement > income Tax Expense
-1334000
Quarters > 1 > income Statement > EBITDA
-12565000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-3292000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
9103000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
4738000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
13841000
Quarters > 1 > balance Sheet > property Plant Equipment
1250000
Quarters > 1 > balance Sheet > total Assets
16605000
Quarters > 1 > balance Sheet > payables
4544000
Quarters > 1 > balance Sheet > short Term Debt
15284000
Quarters > 1 > balance Sheet > long Term Debt
0
Quarters > 1 > balance Sheet > total Liabilities
32105000
Quarters > 1 > balance Sheet > equity
-15500000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-12503000
Quarters > 1 > cash Flow > depreciation
479000
Quarters > 1 > cash Flow > change In Working Capital
1680000
Quarters > 1 > cash Flow > cash From Operations
-4839000
Quarters > 1 > cash Flow > capital Expenditures
197000
Quarters > 1 > cash Flow > cash From Investing
-197000
Quarters > 1 > cash Flow > cash From Financing
-618000
Quarters > 1 > cash Flow > net Change In Cash
-5714000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.013452692851878353
Quarters > 1 > ratios > PB
-709.3458806451613
Quarters > 1 > ratios > ROE
80.66451612903226
Quarters > 1 > ratios > ROA
-75.29659741041856
Quarters > 1 > ratios > FCF
-5036000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2024-04-30
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
532000
Quarters > 2 > income Statement > gross Profit
-532000
Quarters > 2 > income Statement > operating Expenses
9615000
Quarters > 2 > income Statement > operating Income
-10147000
Quarters > 2 > income Statement > interest Expense
596000
Quarters > 2 > income Statement > pretax Income
-5529000
Quarters > 2 > income Statement > net Income
-3311000
Quarters > 2 > income Statement > eps
-0.0036821455420571973
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
899204000
Quarters > 2 > income Statement > income Tax Expense
-2218000
Quarters > 2 > income Statement > EBITDA
-4401000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
4618000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
14817000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
5846000
Quarters > 2 > balance Sheet > inventories
533000
Quarters > 2 > balance Sheet > total Current Assets
21867000
Quarters > 2 > balance Sheet > property Plant Equipment
1709000
Quarters > 2 > balance Sheet > total Assets
23576000
Quarters > 2 > balance Sheet > payables
1461000
Quarters > 2 > balance Sheet > short Term Debt
2034000
Quarters > 2 > balance Sheet > long Term Debt
17366000
Quarters > 2 > balance Sheet > total Liabilities
27081000
Quarters > 2 > balance Sheet > equity
-3505000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-3311000
Quarters > 2 > cash Flow > depreciation
532000
Quarters > 2 > cash Flow > change In Working Capital
533000
Quarters > 2 > cash Flow > cash From Operations
-9247000
Quarters > 2 > cash Flow > capital Expenditures
164000
Quarters > 2 > cash Flow > cash From Investing
-164000
Quarters > 2 > cash Flow > cash From Financing
11160000
Quarters > 2 > cash Flow > net Change In Cash
1738000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0036821455420571973
Quarters > 2 > ratios > PB
-3034.973843081312
Quarters > 2 > ratios > ROE
94.46504992867332
Quarters > 2 > ratios > ROA
-14.04394299287411
Quarters > 2 > ratios > FCF
-9411000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2023-10-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
434000
Quarters > 3 > income Statement > gross Profit
-434000
Quarters > 3 > income Statement > operating Expenses
7686000
Quarters > 3 > income Statement > operating Income
-8120000
Quarters > 3 > income Statement > interest Expense
493000
Quarters > 3 > income Statement > pretax Income
-3588000
Quarters > 3 > income Statement > net Income
-2548000
Quarters > 3 > income Statement > eps
-0.0031098125080857566
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
819342000
Quarters > 3 > income Statement > income Tax Expense
-1040000
Quarters > 3 > income Statement > EBITDA
-2661000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
4532000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
13079000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
476000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
17009000
Quarters > 3 > balance Sheet > property Plant Equipment
1828000
Quarters > 3 > balance Sheet > total Assets
22252000
Quarters > 3 > balance Sheet > payables
1664000
Quarters > 3 > balance Sheet > short Term Debt
2166000
Quarters > 3 > balance Sheet > long Term Debt
18947000
Quarters > 3 > balance Sheet > total Liabilities
30615000
Quarters > 3 > balance Sheet > equity
-11778000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-2548000
Quarters > 3 > cash Flow > depreciation
434000
Quarters > 3 > cash Flow > change In Working Capital
-1244000
Quarters > 3 > cash Flow > cash From Operations
-6653000
Quarters > 3 > cash Flow > capital Expenditures
13000
Quarters > 3 > cash Flow > cash From Investing
-13000
Quarters > 3 > cash Flow > cash From Financing
-175000
Quarters > 3 > cash Flow > net Change In Cash
-6841000
Quarters > 3 > cash Flow > currency_symbol
GBP
Quarters > 3 > ratios > PE
-0.0031098125080857566
Quarters > 3 > ratios > PB
-822.9594039735099
Quarters > 3 > ratios > ROE
21.63355408388521
Quarters > 3 > ratios > ROA
-11.450656120798131
Quarters > 3 > ratios > FCF
-6666000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
38
Annuals > 0 > quarter
2025-04-30
Annuals > 0 > income Statement > revenue
4711000
Annuals > 0 > income Statement > cost Of Revenue
1117000
Annuals > 0 > income Statement > gross Profit
3594000
Annuals > 0 > income Statement > operating Expenses
18595000
Annuals > 0 > income Statement > operating Income
-15001000
Annuals > 0 > income Statement > interest Expense
1717000
Annuals > 0 > income Statement > pretax Income
-15303000
Annuals > 0 > income Statement > net Income
-12272000
Annuals > 0 > income Statement > eps
-0.012647393704780189
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
970318493
Annuals > 0 > income Statement > income Tax Expense
-3031000
Annuals > 0 > income Statement > EBITDA
-12707000
Annuals > 0 > income Statement > operating Margin
-318.42496285289747
Annuals > 0 > income Statement > total Other Income Expense Net
-302000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
16894000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
3730000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
20624000
Annuals > 0 > balance Sheet > property Plant Equipment
847000
Annuals > 0 > balance Sheet > total Assets
23090000
Annuals > 0 > balance Sheet > payables
606000
Annuals > 0 > balance Sheet > short Term Debt
16143999
Annuals > 0 > balance Sheet > long Term Debt
0
Annuals > 0 > balance Sheet > total Liabilities
26925000
Annuals > 0 > balance Sheet > equity
-3835000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-12272000
Annuals > 0 > cash Flow > depreciation
879000
Annuals > 0 > cash Flow > change In Working Capital
732000
Annuals > 0 > cash Flow > cash From Operations
-6106000
Annuals > 0 > cash Flow > capital Expenditures
14000
Annuals > 0 > cash Flow > cash From Investing
-1539000
Annuals > 0 > cash Flow > cash From Financing
9733000
Annuals > 0 > cash Flow > net Change In Cash
2077000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.012647393704780189
Annuals > 0 > ratios > PB
-2530.165561929596
Annuals > 0 > ratios > ROE
320
Annuals > 0 > ratios > ROA
-53.14854915547856
Annuals > 0 > ratios > FCF
-6120000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-1.2990872426236468
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2024-04-30
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
966000
Annuals > 1 > income Statement > gross Profit
-966000
Annuals > 1 > income Statement > operating Expenses
17301000
Annuals > 1 > income Statement > operating Income
-18267000
Annuals > 1 > income Statement > interest Expense
1089000
Annuals > 1 > income Statement > pretax Income
-9117000
Annuals > 1 > income Statement > net Income
-5859000
Annuals > 1 > income Statement > eps
-0.006793169496477616
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
862484000
Annuals > 1 > income Statement > income Tax Expense
-3258000
Annuals > 1 > income Statement > EBITDA
-7062000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
9150000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
14817000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
5846000
Annuals > 1 > balance Sheet > inventories
533000
Annuals > 1 > balance Sheet > total Current Assets
21867000
Annuals > 1 > balance Sheet > property Plant Equipment
1709000
Annuals > 1 > balance Sheet > total Assets
23576000
Annuals > 1 > balance Sheet > payables
1461000
Annuals > 1 > balance Sheet > short Term Debt
2034000
Annuals > 1 > balance Sheet > long Term Debt
17366000
Annuals > 1 > balance Sheet > total Liabilities
27081000
Annuals > 1 > balance Sheet > equity
-3505000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-9117000
Annuals > 1 > cash Flow > depreciation
966000
Annuals > 1 > cash Flow > change In Working Capital
-711000
Annuals > 1 > cash Flow > cash From Operations
-15660000
Annuals > 1 > cash Flow > capital Expenditures
177000
Annuals > 1 > cash Flow > cash From Investing
178000
Annuals > 1 > cash Flow > cash From Financing
10390000
Annuals > 1 > cash Flow > net Change In Cash
-5103000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.006793169496477616
Annuals > 1 > ratios > PB
-2460.7246790299573
Annuals > 1 > ratios > ROE
167.16119828815977
Annuals > 1 > ratios > ROA
-24.851543942992873
Annuals > 1 > ratios > FCF
-15837000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2023-04-30
Annuals > 2 > income Statement > revenue
5271000
Annuals > 2 > income Statement > cost Of Revenue
525000
Annuals > 2 > income Statement > gross Profit
4746000
Annuals > 2 > income Statement > operating Expenses
16666000
Annuals > 2 > income Statement > operating Income
-11920000
Annuals > 2 > income Statement > interest Expense
1215000
Annuals > 2 > income Statement > pretax Income
-14304000
Annuals > 2 > income Statement > net Income
-11936000
Annuals > 2 > income Statement > eps
-0.014620857260451169
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
816368000
Annuals > 2 > income Statement > income Tax Expense
-2368000
Annuals > 2 > income Statement > EBITDA
-12187000
Annuals > 2 > income Statement > operating Margin
-226.14304686017834
Annuals > 2 > income Statement > total Other Income Expense Net
-2384000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
19920000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
4277000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
24606000
Annuals > 2 > balance Sheet > property Plant Equipment
2249000
Annuals > 2 > balance Sheet > total Assets
30270000
Annuals > 2 > balance Sheet > payables
1309000
Annuals > 2 > balance Sheet > short Term Debt
1899000
Annuals > 2 > balance Sheet > long Term Debt
18481000
Annuals > 2 > balance Sheet > total Liabilities
36503000
Annuals > 2 > balance Sheet > equity
-6233000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-14304000
Annuals > 2 > cash Flow > depreciation
902000
Annuals > 2 > cash Flow > change In Working Capital
940000
Annuals > 2 > cash Flow > cash From Operations
-8140000
Annuals > 2 > cash Flow > capital Expenditures
203000
Annuals > 2 > cash Flow > cash From Investing
81000
Annuals > 2 > cash Flow > cash From Financing
-746000
Annuals > 2 > cash Flow > net Change In Cash
-8805000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.014620857260451169
Annuals > 2 > ratios > PB
-1309.7513236001926
Annuals > 2 > ratios > ROE
191.49687149045405
Annuals > 2 > ratios > ROA
-39.43178064089858
Annuals > 2 > ratios > FCF
-8343000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-1.582811610700057
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2022-04-30
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
740000
Annuals > 3 > income Statement > gross Profit
-740000
Annuals > 3 > income Statement > operating Expenses
13524000
Annuals > 3 > income Statement > operating Income
-14264000
Annuals > 3 > income Statement > interest Expense
2882000
Annuals > 3 > income Statement > pretax Income
-6272000
Annuals > 3 > income Statement > net Income
-2065000
Annuals > 3 > income Statement > eps
-0.002532080168233123
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
815535000
Annuals > 3 > income Statement > income Tax Expense
-1703000
Annuals > 3 > income Statement > EBITDA
-3755000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
7027000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
41110000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
647000
Annuals > 3 > balance Sheet > inventories
-79000
Annuals > 3 > balance Sheet > total Current Assets
32362000
Annuals > 3 > balance Sheet > property Plant Equipment
975000
Annuals > 3 > balance Sheet > total Assets
49058000
Annuals > 3 > balance Sheet > payables
2137000
Annuals > 3 > balance Sheet > short Term Debt
1735000
Annuals > 3 > balance Sheet > long Term Debt
7008000
Annuals > 3 > balance Sheet > total Liabilities
29573000
Annuals > 3 > balance Sheet > equity
18110000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-6272000
Annuals > 3 > cash Flow > depreciation
740000
Annuals > 3 > cash Flow > change In Working Capital
372000
Annuals > 3 > cash Flow > cash From Operations
-7803000
Annuals > 3 > cash Flow > capital Expenditures
744000
Annuals > 3 > cash Flow > cash From Investing
-741000
Annuals > 3 > cash Flow > cash From Financing
46079000
Annuals > 3 > cash Flow > net Change In Cash
37535000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.002532080168233123
Annuals > 3 > ratios > PB
450.3230259525124
Annuals > 3 > ratios > ROE
-11.402540033130867
Annuals > 3 > ratios > ROA
-4.209303273676057
Annuals > 3 > ratios > FCF
-8547000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
17
Valuation > metrics > PE
0.00023806616246774964
Valuation > metrics > PB
-2993.185859762712
Valuation > final Score
70
Valuation > verdict
100.0% Undervalued
Profitability > metrics > ROE
-6.023468057366363
Profitability > metrics > ROA
1.120054305663305
Profitability > metrics > Net Margin
0.04903417533432392
Profitability > final Score
11
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-4.822510822510822
Risk > final Score
11
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.2312836555990243
Liquidity > metrics > Quick Ratio
1.2312836555990243
Liquidity > final Score
81
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
55
Prev Profitabilities > 2
55
Prev Risks > 0
-23
Prev Risks > 1
-38
Prev Risks > 2
-36
Prev Liquidities > 0
45
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:03:54.862Z
Earnings History > 0 > period
2025-07-31
Earnings History > 0 > report Date
2025-09-11
Earnings History > 0 > date
2025-07-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-10-31
Earnings History > 1 > report Date
2025-01-30
Earnings History > 1 > date
2024-10-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.01
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.01
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2022-10-31
Earnings History > 2 > report Date
2023-01-25
Earnings History > 2 > date
2022-10-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
GBP
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-07-31
Earnings History > 3 > report Date
2022-10-28
Earnings History > 3 > date
2022-07-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
-0.01
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2021-10-31
Earnings History > 4 > report Date
2021-12-22
Earnings History > 4 > date
2021-10-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-07-31
Earnings History > 5 > report Date
2021-10-29
Earnings History > 5 > date
2021-07-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-0.01
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2020-10-31
Earnings History > 6 > report Date
2021-01-29
Earnings History > 6 > date
2020-10-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.01
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.01
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-07-31
Earnings History > 7 > report Date
2020-10-16
Earnings History > 7 > date
2020-07-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
-0.01
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-10-31
Earnings History > 8 > report Date
2020-01-31
Earnings History > 8 > date
2019-10-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
-0.01
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-07-31
Earnings History > 9 > report Date
2019-08-20
Earnings History > 9 > date
2019-07-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
-0.01
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.01
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-10-31
Earnings History > 10 > report Date
2019-01-31
Earnings History > 10 > date
2018-10-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
-0.01
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.01
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-07-31
Earnings History > 11 > report Date
2018-09-25
Earnings History > 11 > date
2018-07-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
-0.01
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.01
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2017-10-31
Earnings History > 12 > report Date
2018-01-30
Earnings History > 12 > date
2017-10-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
-0.01
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.01
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-07-31
Earnings History > 13 > report Date
2017-09-13
Earnings History > 13 > date
2017-07-31
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
-0.01
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.01
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2016-10-31
Earnings History > 14 > report Date
2017-01-31
Earnings History > 14 > date
2016-10-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
-0.01
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.01
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-04-30
Earnings History > 15 > report Date
2016-06-04
Earnings History > 15 > date
2016-04-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
-0.01
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.01
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2015-10-31
Earnings History > 16 > report Date
2016-01-27
Earnings History > 16 > date
2015-10-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
-0.01
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.01
Earnings History > 16 > surprise Percent
-
Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer. It also develops Modi-1, an active peptide immunotherapy that is in phase II clinical trials for the treatment of solid tumors, including renal, head and neck, ovarian and triple negative breast cancers; and Modi-2, which targets stress-induced post translational modifications, such as homocittrullination. In addition, the company provides GlyMab platform that generates various affinity tumour specific monoclonal antibodies (mAb) targeting glycans that are over-expressed on cancer cells; and AvidiMab, which romotes receptor clustering thereby improving immune signalling. Scancell Holdings plc was founded in 1996 and is based in Oxford, the United Kingdom.
Stock Price
GBp 0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AScancell (LON:SCLP) Shares Cross Below 200-Day Moving Average – What’s Next? - Defense World
1/3/2026
Scancell (LON:SCLP) Shares Cross Below 200-Day Moving Average – What’s Next? Defense World
Read more →Showing 2 of 8
(Last Updated 2025-04-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-04-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Scancell Hldgs Plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-07-31
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-04-30)
(Last Updated 2025-04-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-04-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-04-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.